- HOME
- Products & Services
- Oligonucleotide API CDMO – Service Overview
Oligonucleotide API CDMO – Service Overview
Comprehensive support from oligonucleotide therapeutics research to API production with our reliable technology
Service Description
Hokkaido System Science Co., Ltd. (HSS) comprehensively supports a series of steps in the research and development of oligonucleotide therapeutics, including sequence design, synthesis, and gene analysis after in vitro and in vivo administration.
From January 2026, GMP-compliant oligonucleotide synthesis will be available in collaboration with Mitsubishi Gas Chemical Company, Inc. (MGC).
We can provide a comprehensive support system from the early stage of research through to oligonucleotide API manufacturing.
Related Articles
Features of HSS Custom Services
1
Flexible ordering is available from spot requests to total contracts for sequence design, synthesis, and gene analysis (evaluation system).
2
Discount plans can be offered when ordering a combination of several services or an annual contract.
3
We can advise on research funding / grant proposal as a collaboration business.
A customized service plan will be proposed based on your consultation details, including schedule, budget, necessary processes, and issues.
Contact & Consultation
If you have any questions or would like to request a quote,
please feel free to contact us using the form below.